Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 93,375 |
|
|||||
| News | - | ||||||
| Day High | 0.7699 | Low High |
|||||
| Day Low | 0.72 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aptevo Therapeutics Inc | APVO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0262 | -3.40% | 0.7438 | 09:48:48 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.72 | 0.72 | 0.7699 | 0.77 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 201 | 93,375 | $ 0.7333139 | $ 68,473 | - | 0.70 - 91.96 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:48:21 | 100 | $ 0.7438 | USD |
Aptevo Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 400.1k | 533.46k | - | 0 | -17.41M | -32.64 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aptevo Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APVO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.9265 | 0.9265 | 0.70 | 0.78657 | 494,502 | -0.1827 | -19.72% |
| 1 Month | 4.64 | 4.9979 | 0.70 | 1.65 | 532,553 | -3.90 | -83.97% |
| 3 Months | 7.0004 | 10.80 | 0.70 | 4.75 | 488,674 | -6.26 | -89.37% |
| 6 Months | 15.84 | 16.5704 | 0.70 | 6.92 | 461,539 | -15.10 | -95.30% |
| 1 Year | 83.16 | 91.96 | 0.70 | 15.78 | 377,723 | -82.42 | -99.11% |
| 3 Years | 1,100.00 | 1,397.44 | 0.70 | 431.85 | 527,491 | -1,099.26 | -99.93% |
| 5 Years | 35.20 | 2,640.00 | 0.70 | 428.60 | 556,267 | -34.46 | -97.89% |
Aptevo Therapeutics Description
| Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. |
